Form 4: Zimmer Biomet Director Kolli Reports Acquisition of Phantom Stock Units and Restricted Stock Units

Director Sreelakshmi Kolli reports acquisition of phantom stock units and restricted stock units in Zimmer Biomet Holdings, Inc.

Summary

• On May 10, 2024, Sreelakshmi Kolli, a director of Zimmer Biomet Holdings, Inc., reported the acquisition of 616.726 phantom stock units and 1,068.991 restricted stock units.
• The phantom stock units were accrued under the company's Deferred Compensation Plan for Non-Employee Directors.
• These units will be settled in shares of company common stock within sixty days after cessation of the reporting person's service as a director.
• The restricted stock units are immediately 100% vested and will be subject to mandatory deferral until the later of the director's termination of service or three years after the grant date.
• Following the reported transactions, Kolli beneficially owns 3,628.53 phantom stock units and 3,952.928 restricted stock units.

Sentiment

Score: 6

Explanation: The document is a neutral regulatory filing. The acquisition of stock units by a director is generally viewed as a slightly positive signal, but it's a routine event.

Positives

• The acquisition of stock units by a director can be seen as a positive sign, indicating confidence in the company's future performance.
• The vesting and deferral terms of the restricted stock units align the director's interests with the long-term success of the company.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting and deferral terms of the restricted stock units suggest a long-term commitment from the director.

Industry Context

This filing is a routine disclosure related to insider transactions. It reflects standard compensation practices for directors of publicly traded companies in the medical device industry.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash, stock options, and restricted stock units to align their interests with shareholders.
• Companies like Stryker and Medtronic also utilize similar deferred compensation plans for their non-employee directors.
• The vesting schedules and deferral periods for restricted stock units are generally in line with industry norms, typically ranging from immediate vesting to several years.

Stakeholder Impact

• The acquisition of stock units by a director can have a minor positive impact on shareholder sentiment.
• The vesting and deferral terms of the restricted stock units align the director's interests with the long-term success of the company, which benefits shareholders.

Key Dates